company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,,2014-03-31,2014-05-13 16:15:55+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,53877000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,,2014-03-31,2014-05-13 16:15:55+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,3752000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,,2014-03-31,2014-05-13 16:15:55+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,585000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,,2014-03-31,2014-05-13 16:15:55+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,58214000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,,2014-03-31,2014-05-13 16:15:55+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,353000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,,2014-03-31,2014-05-13 16:15:55+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,11000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,,2014-03-31,2014-05-13 16:15:55+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,11000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,,2014-03-31,2014-05-13 16:15:55+00:00,,totalassets,Total Assets,=,debit,usd,58578000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,,2014-03-31,2014-05-13 16:15:55+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,,2014-03-31,2014-05-13 16:15:55+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1754000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,,2014-03-31,2014-05-13 16:15:55+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,2208000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,,2014-03-31,2014-05-13 16:15:55+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,,2014-03-31,2014-05-13 16:15:55+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,,2014-03-31,2014-05-13 16:15:55+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,3962000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,,2014-03-31,2014-05-13 16:15:55+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,35000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,,2014-03-31,2014-05-13 16:15:55+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,35000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,,2014-03-31,2014-05-13 16:15:55+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,3997000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,,2014-03-31,2014-05-13 16:15:55+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,,2014-03-31,2014-05-13 16:15:55+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,,2014-03-31,2014-05-13 16:15:55+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,,2014-03-31,2014-05-13 16:15:55+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,174329000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,,2014-03-31,2014-05-13 16:15:55+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-119748000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,,2014-03-31,2014-05-13 16:15:55+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,,2014-03-31,2014-05-13 16:15:55+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,54581000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,,2014-03-31,2014-05-13 16:15:55+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,54581000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,,2014-03-31,2014-05-13 16:15:55+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,54581000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,,2014-03-31,2014-05-13 16:15:55+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,58578000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,,2014-06-30,2014-08-06 21:08:15+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,13371000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,,2014-06-30,2014-08-06 21:08:15+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,37801000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,,2014-06-30,2014-08-06 21:08:15+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,590000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,,2014-06-30,2014-08-06 21:08:15+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,51762000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,,2014-06-30,2014-08-06 21:08:15+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,367000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,,2014-06-30,2014-08-06 21:08:15+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,149000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,,2014-06-30,2014-08-06 21:08:15+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,149000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,,2014-06-30,2014-08-06 21:08:15+00:00,,totalassets,Total Assets,=,debit,usd,52278000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,,2014-06-30,2014-08-06 21:08:15+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,,2014-06-30,2014-08-06 21:08:15+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2145000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,,2014-06-30,2014-08-06 21:08:15+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1523000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,,2014-06-30,2014-08-06 21:08:15+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,,2014-06-30,2014-08-06 21:08:15+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,,2014-06-30,2014-08-06 21:08:15+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,3668000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,,2014-06-30,2014-08-06 21:08:15+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,46000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,,2014-06-30,2014-08-06 21:08:15+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,46000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,,2014-06-30,2014-08-06 21:08:15+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,3714000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,,2014-06-30,2014-08-06 21:08:15+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,,2014-06-30,2014-08-06 21:08:15+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,,2014-06-30,2014-08-06 21:08:15+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,,2014-06-30,2014-08-06 21:08:15+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,175286000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,,2014-06-30,2014-08-06 21:08:15+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-126740000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,,2014-06-30,2014-08-06 21:08:15+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,18000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,,2014-06-30,2014-08-06 21:08:15+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,48564000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,,2014-06-30,2014-08-06 21:08:15+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,48564000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,,2014-06-30,2014-08-06 21:08:15+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,48564000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,,2014-06-30,2014-08-06 21:08:15+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,52278000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,,2014-09-30,2014-11-12 06:31:30+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,14367000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,,2014-09-30,2014-11-12 06:31:30+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,80755000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,,2014-09-30,2014-11-12 06:31:30+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,891000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,,2014-09-30,2014-11-12 06:31:30+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,96013000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,,2014-09-30,2014-11-12 06:31:30+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,616000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,,2014-09-30,2014-11-12 06:31:30+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,280000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,,2014-09-30,2014-11-12 06:31:30+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,280000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,,2014-09-30,2014-11-12 06:31:30+00:00,,totalassets,Total Assets,=,debit,usd,96909000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,,2014-09-30,2014-11-12 06:31:30+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,,2014-09-30,2014-11-12 06:31:30+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3959000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,,2014-09-30,2014-11-12 06:31:30+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,867000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,,2014-09-30,2014-11-12 06:31:30+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,,2014-09-30,2014-11-12 06:31:30+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,86000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,,2014-09-30,2014-11-12 06:31:30+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,4912000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,,2014-09-30,2014-11-12 06:31:30+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,9911000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,,2014-09-30,2014-11-12 06:31:30+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,111000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,,2014-09-30,2014-11-12 06:31:30+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,10022000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,,2014-09-30,2014-11-12 06:31:30+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,14934000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,,2014-09-30,2014-11-12 06:31:30+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,,2014-09-30,2014-11-12 06:31:30+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,,2014-09-30,2014-11-12 06:31:30+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,,2014-09-30,2014-11-12 06:31:30+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,217081000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,,2014-09-30,2014-11-12 06:31:30+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-135098000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,,2014-09-30,2014-11-12 06:31:30+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-8000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,,2014-09-30,2014-11-12 06:31:30+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,81975000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,,2014-09-30,2014-11-12 06:31:30+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,81975000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,,2014-09-30,2014-11-12 06:31:30+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,81975000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,,2014-09-30,2014-11-12 06:31:30+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,96909000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,,2015-03-31,2015-05-14 19:48:56+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,50018000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,,2015-03-31,2015-05-14 19:48:56+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,20570000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,,2015-03-31,2015-05-14 19:48:56+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1673000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,,2015-03-31,2015-05-14 19:48:56+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,72261000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,,2015-03-31,2015-05-14 19:48:56+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,793000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,,2015-03-31,2015-05-14 19:48:56+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,185000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,,2015-03-31,2015-05-14 19:48:56+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,185000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,,2015-03-31,2015-05-14 19:48:56+00:00,,totalassets,Total Assets,=,debit,usd,73239000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,,2015-03-31,2015-05-14 19:48:56+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1671000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,,2015-03-31,2015-05-14 19:48:56+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3746000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,,2015-03-31,2015-05-14 19:48:56+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,646000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,,2015-03-31,2015-05-14 19:48:56+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,71000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,,2015-03-31,2015-05-14 19:48:56+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,6134000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,,2015-03-31,2015-05-14 19:48:56+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,8710000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,,2015-03-31,2015-05-14 19:48:56+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,291000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,,2015-03-31,2015-05-14 19:48:56+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,9001000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,,2015-03-31,2015-05-14 19:48:56+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,15135000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,,2015-03-31,2015-05-14 19:48:56+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,,2015-03-31,2015-05-14 19:48:56+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,,2015-03-31,2015-05-14 19:48:56+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,221290000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,,2015-03-31,2015-05-14 19:48:56+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-163185000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,,2015-03-31,2015-05-14 19:48:56+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-1000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,,2015-03-31,2015-05-14 19:48:56+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,58104000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,,2015-03-31,2015-05-14 19:48:56+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,58104000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,,2015-03-31,2015-05-14 19:48:56+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,58104000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,,2015-03-31,2015-05-14 19:48:56+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,73239000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,,2015-06-30,2015-08-11 16:47:19+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,50041000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,,2015-06-30,2015-08-11 16:47:19+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,8004000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,,2015-06-30,2015-08-11 16:47:19+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1165000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,,2015-06-30,2015-08-11 16:47:19+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,59210000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,,2015-06-30,2015-08-11 16:47:19+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,616000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,,2015-06-30,2015-08-11 16:47:19+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,127000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,,2015-06-30,2015-08-11 16:47:19+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,127000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,,2015-06-30,2015-08-11 16:47:19+00:00,,totalassets,Total Assets,=,debit,usd,59953000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,,2015-06-30,2015-08-11 16:47:19+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,10587000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,,2015-06-30,2015-08-11 16:47:19+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3446000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,,2015-06-30,2015-08-11 16:47:19+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,342000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,,2015-06-30,2015-08-11 16:47:19+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,2392000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,,2015-06-30,2015-08-11 16:47:19+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,69000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,,2015-06-30,2015-08-11 16:47:19+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,16836000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,,2015-06-30,2015-08-11 16:47:19+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,10000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,,2015-06-30,2015-08-11 16:47:19+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,283000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,,2015-06-30,2015-08-11 16:47:19+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,293000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,,2015-06-30,2015-08-11 16:47:19+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,17129000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,,2015-06-30,2015-08-11 16:47:19+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,,2015-06-30,2015-08-11 16:47:19+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,,2015-06-30,2015-08-11 16:47:19+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,222534000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,,2015-06-30,2015-08-11 16:47:19+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-179710000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,,2015-06-30,2015-08-11 16:47:19+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,,2015-06-30,2015-08-11 16:47:19+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,42824000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,,2015-06-30,2015-08-11 16:47:19+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,42824000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,,2015-06-30,2015-08-11 16:47:19+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,42824000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,,2015-06-30,2015-08-11 16:47:19+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,59953000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,,2015-09-30,2015-11-09 16:57:27+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,37092000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,,2015-09-30,2015-11-09 16:57:27+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,,2015-09-30,2015-11-09 16:57:27+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1001000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,,2015-09-30,2015-11-09 16:57:27+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,38093000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,,2015-09-30,2015-11-09 16:57:27+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,133000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,,2015-09-30,2015-11-09 16:57:27+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,10000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,,2015-09-30,2015-11-09 16:57:27+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,10000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,,2015-09-30,2015-11-09 16:57:27+00:00,,totalassets,Total Assets,=,debit,usd,38236000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,,2015-09-30,2015-11-09 16:57:27+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,,2015-09-30,2015-11-09 16:57:27+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1025000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,,2015-09-30,2015-11-09 16:57:27+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,163000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,,2015-09-30,2015-11-09 16:57:27+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,609000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,,2015-09-30,2015-11-09 16:57:27+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,,2015-09-30,2015-11-09 16:57:27+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,1797000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,,2015-09-30,2015-11-09 16:57:27+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,,2015-09-30,2015-11-09 16:57:27+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,29000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,,2015-09-30,2015-11-09 16:57:27+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,29000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,,2015-09-30,2015-11-09 16:57:27+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1826000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,,2015-09-30,2015-11-09 16:57:27+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,,2015-09-30,2015-11-09 16:57:27+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,,2015-09-30,2015-11-09 16:57:27+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,222516000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,,2015-09-30,2015-11-09 16:57:27+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-186106000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,,2015-09-30,2015-11-09 16:57:27+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,,2015-09-30,2015-11-09 16:57:27+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,36410000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,,2015-09-30,2015-11-09 16:57:27+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,36410000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,,2015-09-30,2015-11-09 16:57:27+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,36410000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,,2015-09-30,2015-11-09 16:57:27+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,38236000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,,2016-03-31,2016-05-16 14:05:04+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,61197000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,,2016-03-31,2016-05-16 14:05:04+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,475000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,,2016-03-31,2016-05-16 14:05:04+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,61672000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,,2016-03-31,2016-05-16 14:05:04+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,46000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,,2016-03-31,2016-05-16 14:05:04+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,155000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,,2016-03-31,2016-05-16 14:05:04+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,155000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,,2016-03-31,2016-05-16 14:05:04+00:00,,totalassets,Total Assets,=,debit,usd,61873000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,,2016-03-31,2016-05-16 14:05:04+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6062000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,,2016-03-31,2016-05-16 14:05:04+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,2049000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,,2016-03-31,2016-05-16 14:05:04+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,8111000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,,2016-03-31,2016-05-16 14:05:04+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,15000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,,2016-03-31,2016-05-16 14:05:04+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,15000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,,2016-03-31,2016-05-16 14:05:04+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,8126000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,,2016-03-31,2016-05-16 14:05:04+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,92766000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,,2016-03-31,2016-05-16 14:05:04+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-39019000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,,2016-03-31,2016-05-16 14:05:04+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,53747000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,,2016-03-31,2016-05-16 14:05:04+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,53747000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,,2016-03-31,2016-05-16 14:05:04+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,53747000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,,2016-03-31,2016-05-16 14:05:04+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,61873000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,,2017-03-31,2017-05-12 12:05:19+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,14451000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,,2017-03-31,2017-05-12 12:05:19+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,34573000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,,2017-03-31,2017-05-12 12:05:19+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,529000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,,2017-03-31,2017-05-12 12:05:19+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,49553000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,,2017-03-31,2017-05-12 12:05:19+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,90000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,,2017-03-31,2017-05-12 12:05:19+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,124000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,,2017-03-31,2017-05-12 12:05:19+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,124000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,,2017-03-31,2017-05-12 12:05:19+00:00,,totalassets,Total Assets,=,debit,usd,49767000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,,2017-03-31,2017-05-12 12:05:19+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3187000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,,2017-03-31,2017-05-12 12:05:19+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,910000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,,2017-03-31,2017-05-12 12:05:19+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,4097000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,,2017-03-31,2017-05-12 12:05:19+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,14800000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,,2017-03-31,2017-05-12 12:05:19+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,14800000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,,2017-03-31,2017-05-12 12:05:19+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,18897000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,,2017-03-31,2017-05-12 12:05:19+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,118475000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,,2017-03-31,2017-05-12 12:05:19+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-87597000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,,2017-03-31,2017-05-12 12:05:19+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-8000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,,2017-03-31,2017-05-12 12:05:19+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,30870000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,,2017-03-31,2017-05-12 12:05:19+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,30870000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,,2017-03-31,2017-05-12 12:05:19+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,30870000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,,2017-03-31,2017-05-12 12:05:19+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,49767000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,,2017-06-30,2017-08-11 16:31:15+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,11197000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,,2017-06-30,2017-08-11 16:31:15+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,29112000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,,2017-06-30,2017-08-11 16:31:15+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,969000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,,2017-06-30,2017-08-11 16:31:15+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,41278000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,,2017-06-30,2017-08-11 16:31:15+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,101000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,,2017-06-30,2017-08-11 16:31:15+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,81000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,,2017-06-30,2017-08-11 16:31:15+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,81000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,,2017-06-30,2017-08-11 16:31:15+00:00,,totalassets,Total Assets,=,debit,usd,41460000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,,2017-06-30,2017-08-11 16:31:15+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4468000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,,2017-06-30,2017-08-11 16:31:15+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1422000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,,2017-06-30,2017-08-11 16:31:15+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,5890000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,,2017-06-30,2017-08-11 16:31:15+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,14898000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,,2017-06-30,2017-08-11 16:31:15+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,14898000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,,2017-06-30,2017-08-11 16:31:15+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,20788000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,,2017-06-30,2017-08-11 16:31:15+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,119421000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,,2017-06-30,2017-08-11 16:31:15+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-98743000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,,2017-06-30,2017-08-11 16:31:15+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-6000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,,2017-06-30,2017-08-11 16:31:15+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,20672000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,,2017-06-30,2017-08-11 16:31:15+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,20672000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,,2017-06-30,2017-08-11 16:31:15+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,20672000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,,2017-06-30,2017-08-11 16:31:15+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,41460000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,,2017-09-30,2017-11-09 16:41:34+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,13078000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,,2017-09-30,2017-11-09 16:41:34+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,19264000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,,2017-09-30,2017-11-09 16:41:34+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,783000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,,2017-09-30,2017-11-09 16:41:34+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,33125000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,,2017-09-30,2017-11-09 16:41:34+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,90000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,,2017-09-30,2017-11-09 16:41:34+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,66000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,,2017-09-30,2017-11-09 16:41:34+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,66000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,,2017-09-30,2017-11-09 16:41:34+00:00,,totalassets,Total Assets,=,debit,usd,33281000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,,2017-09-30,2017-11-09 16:41:34+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4167000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,,2017-09-30,2017-11-09 16:41:34+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1566000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,,2017-09-30,2017-11-09 16:41:34+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,5733000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,,2017-09-30,2017-11-09 16:41:34+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,14993000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,,2017-09-30,2017-11-09 16:41:34+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,14993000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,,2017-09-30,2017-11-09 16:41:34+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,20726000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,,2017-09-30,2017-11-09 16:41:34+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,120470000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,,2017-09-30,2017-11-09 16:41:34+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-107913000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,,2017-09-30,2017-11-09 16:41:34+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-2000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,,2017-09-30,2017-11-09 16:41:34+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,12555000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,,2017-09-30,2017-11-09 16:41:34+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,12555000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,,2017-09-30,2017-11-09 16:41:34+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,12555000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,,2017-09-30,2017-11-09 16:41:34+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,33281000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,,2018-03-31,2018-05-11 16:16:18+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,33247000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,,2018-03-31,2018-05-11 16:16:18+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,,2018-03-31,2018-05-11 16:16:18+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,617000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,,2018-03-31,2018-05-11 16:16:18+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,33864000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,,2018-03-31,2018-05-11 16:16:18+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,68000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,,2018-03-31,2018-05-11 16:16:18+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,289000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,,2018-03-31,2018-05-11 16:16:18+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,289000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,,2018-03-31,2018-05-11 16:16:18+00:00,,totalassets,Total Assets,=,debit,usd,34221000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,,2018-03-31,2018-05-11 16:16:18+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,3253000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,,2018-03-31,2018-05-11 16:16:18+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3025000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,,2018-03-31,2018-05-11 16:16:18+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1224000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,,2018-03-31,2018-05-11 16:16:18+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,7502000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,,2018-03-31,2018-05-11 16:16:18+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,11938000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,,2018-03-31,2018-05-11 16:16:18+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,50000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,,2018-03-31,2018-05-11 16:16:18+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,11988000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,,2018-03-31,2018-05-11 16:16:18+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,19490000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,,2018-03-31,2018-05-11 16:16:18+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,142368000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,,2018-03-31,2018-05-11 16:16:18+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-127637000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,,2018-03-31,2018-05-11 16:16:18+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,,2018-03-31,2018-05-11 16:16:18+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,14731000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,,2018-03-31,2018-05-11 16:16:18+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,14731000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,,2018-03-31,2018-05-11 16:16:18+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,14731000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,,2018-03-31,2018-05-11 16:16:18+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,34221000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,,2018-06-30,2018-08-10 07:31:46+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,33323000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,,2018-06-30,2018-08-10 07:31:46+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,40169000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,,2018-06-30,2018-08-10 07:31:46+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1485000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,,2018-06-30,2018-08-10 07:31:46+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,74977000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,,2018-06-30,2018-08-10 07:31:46+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,71000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,,2018-06-30,2018-08-10 07:31:46+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,290000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,,2018-06-30,2018-08-10 07:31:46+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,290000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,,2018-06-30,2018-08-10 07:31:46+00:00,,totalassets,Total Assets,=,debit,usd,75338000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,,2018-06-30,2018-08-10 07:31:46+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,3242000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,,2018-06-30,2018-08-10 07:31:46+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4438000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,,2018-06-30,2018-08-10 07:31:46+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1152000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,,2018-06-30,2018-08-10 07:31:46+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,8832000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,,2018-06-30,2018-08-10 07:31:46+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,17032000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,,2018-06-30,2018-08-10 07:31:46+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,193000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,,2018-06-30,2018-08-10 07:31:46+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,17225000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,,2018-06-30,2018-08-10 07:31:46+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,26057000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,,2018-06-30,2018-08-10 07:31:46+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,186847000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,,2018-06-30,2018-08-10 07:31:46+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-137552000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,,2018-06-30,2018-08-10 07:31:46+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-14000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,,2018-06-30,2018-08-10 07:31:46+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,49281000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,,2018-06-30,2018-08-10 07:31:46+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,49281000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,,2018-06-30,2018-08-10 07:31:46+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,49281000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,,2018-06-30,2018-08-10 07:31:46+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,75338000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,,2018-09-30,2018-11-09 16:16:45+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,16927000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,,2018-09-30,2018-11-09 16:16:45+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,48013000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,,2018-09-30,2018-11-09 16:16:45+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1864000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,,2018-09-30,2018-11-09 16:16:45+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,66804000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,,2018-09-30,2018-11-09 16:16:45+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,185000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,,2018-09-30,2018-11-09 16:16:45+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,389000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,,2018-09-30,2018-11-09 16:16:45+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,389000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,,2018-09-30,2018-11-09 16:16:45+00:00,,totalassets,Total Assets,=,debit,usd,67378000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,,2018-09-30,2018-11-09 16:16:45+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,6565000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,,2018-09-30,2018-11-09 16:16:45+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6517000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,,2018-09-30,2018-11-09 16:16:45+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1459000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,,2018-09-30,2018-11-09 16:16:45+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,14541000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,,2018-09-30,2018-11-09 16:16:45+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,18856000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,,2018-09-30,2018-11-09 16:16:45+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,214000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,,2018-09-30,2018-11-09 16:16:45+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,19070000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,,2018-09-30,2018-11-09 16:16:45+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,33611000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,,2018-09-30,2018-11-09 16:16:45+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,188469000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,,2018-09-30,2018-11-09 16:16:45+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-154696000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,,2018-09-30,2018-11-09 16:16:45+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-6000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,,2018-09-30,2018-11-09 16:16:45+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,33767000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,,2018-09-30,2018-11-09 16:16:45+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,33767000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,,2018-09-30,2018-11-09 16:16:45+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,33767000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,,2018-09-30,2018-11-09 16:16:45+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,67378000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,,2019-03-31,2019-05-09 16:17:04+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,63407000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,,2019-03-31,2019-05-09 16:17:04+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,22385000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,,2019-03-31,2019-05-09 16:17:04+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2594000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,,2019-03-31,2019-05-09 16:17:04+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,88386000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,,2019-03-31,2019-05-09 16:17:04+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,155000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,,2019-03-31,2019-05-09 16:17:04+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,4567000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,,2019-03-31,2019-05-09 16:17:04+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,4567000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,,2019-03-31,2019-05-09 16:17:04+00:00,,totalassets,Total Assets,=,debit,usd,93108000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,,2019-03-31,2019-05-09 16:17:04+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5523000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,,2019-03-31,2019-05-09 16:17:04+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4863000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,,2019-03-31,2019-05-09 16:17:04+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,439000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,,2019-03-31,2019-05-09 16:17:04+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,10825000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,,2019-03-31,2019-05-09 16:17:04+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,29844000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,,2019-03-31,2019-05-09 16:17:04+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1631000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,,2019-03-31,2019-05-09 16:17:04+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,31475000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,,2019-03-31,2019-05-09 16:17:04+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,42300000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,,2019-03-31,2019-05-09 16:17:04+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,239189000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,,2019-03-31,2019-05-09 16:17:04+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-188386000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,,2019-03-31,2019-05-09 16:17:04+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,5000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,,2019-03-31,2019-05-09 16:17:04+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,50808000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,,2019-03-31,2019-05-09 16:17:04+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,50808000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,,2019-03-31,2019-05-09 16:17:04+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,50808000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,,2019-03-31,2019-05-09 16:17:04+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,93108000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,,2019-06-30,2019-08-08 16:31:21+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,58421000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,,2019-06-30,2019-08-08 16:31:21+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,66914000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,,2019-06-30,2019-08-08 16:31:21+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3033000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,,2019-06-30,2019-08-08 16:31:21+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,128368000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,,2019-06-30,2019-08-08 16:31:21+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,200000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,,2019-06-30,2019-08-08 16:31:21+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,4359000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,,2019-06-30,2019-08-08 16:31:21+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,4359000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,,2019-06-30,2019-08-08 16:31:21+00:00,,totalassets,Total Assets,=,debit,usd,132927000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,,2019-06-30,2019-08-08 16:31:21+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,7194000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,,2019-06-30,2019-08-08 16:31:21+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5671000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,,2019-06-30,2019-08-08 16:31:21+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,452000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,,2019-06-30,2019-08-08 16:31:21+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,13317000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,,2019-06-30,2019-08-08 16:31:21+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,30019000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,,2019-06-30,2019-08-08 16:31:21+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1512000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,,2019-06-30,2019-08-08 16:31:21+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,31531000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,,2019-06-30,2019-08-08 16:31:21+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,44848000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,,2019-06-30,2019-08-08 16:31:21+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,293987000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,,2019-06-30,2019-08-08 16:31:21+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-205913000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,,2019-06-30,2019-08-08 16:31:21+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,5000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,,2019-06-30,2019-08-08 16:31:21+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,88079000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,,2019-06-30,2019-08-08 16:31:21+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,88079000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,,2019-06-30,2019-08-08 16:31:21+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,88079000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,,2019-06-30,2019-08-08 16:31:21+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,132927000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,,2019-09-30,2019-11-07 16:21:33+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,19406000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,,2019-09-30,2019-11-07 16:21:33+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,90545000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,,2019-09-30,2019-11-07 16:21:33+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4459000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,,2019-09-30,2019-11-07 16:21:33+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,114410000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,,2019-09-30,2019-11-07 16:21:33+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,538000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,,2019-09-30,2019-11-07 16:21:33+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,5047000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,,2019-09-30,2019-11-07 16:21:33+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,5047000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,,2019-09-30,2019-11-07 16:21:33+00:00,,totalassets,Total Assets,=,debit,usd,119995000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,,2019-09-30,2019-11-07 16:21:33+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,9057000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,,2019-09-30,2019-11-07 16:21:33+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,7222000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,,2019-09-30,2019-11-07 16:21:33+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,466000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,,2019-09-30,2019-11-07 16:21:33+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,16745000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,,2019-09-30,2019-11-07 16:21:33+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,30202000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,,2019-09-30,2019-11-07 16:21:33+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1389000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,,2019-09-30,2019-11-07 16:21:33+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,31591000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,,2019-09-30,2019-11-07 16:21:33+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,48336000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,,2019-09-30,2019-11-07 16:21:33+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,296145000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,,2019-09-30,2019-11-07 16:21:33+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-224529000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,,2019-09-30,2019-11-07 16:21:33+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,43000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,,2019-09-30,2019-11-07 16:21:33+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,71659000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,,2019-09-30,2019-11-07 16:21:33+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,71659000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,,2019-09-30,2019-11-07 16:21:33+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,71659000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,,2019-09-30,2019-11-07 16:21:33+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,119995000.0
